Skip to main content
. 2021 Nov 11;169:229–311. doi: 10.1016/j.resuscitation.2021.10.040

Reviewer Disclosures.

Reviewer Employment Research grant Other research support Speakers’ bureau/honoraria Expert witness Ownership interest Consultant/advisory board Other
Marieke T. Blom Amsterdam University Medical Center (The Netherlands) European Union (Horizon 2020 grant ESCAPE-NET [grant no. 733381]); Netherlands CardioVascular Research Initiative (Dutch Heart Foundation, Dutch Federation of University Medical Centers, Netherlands Organization for Health Research and Development, and Royal Netherlands Academy of Sciences) (grant CVON-2018-30 Predict 2) None None None None Scientific Board of Dutch Resuscitation Council* None
Patricia Conaghan University of Manchester (United Kingdom) None None None None None None None
Koert de Waal John Hunter Children’s Hospital (Australia) None None None None None None None
Gustavo E. Flores Emergency & Critical Care Trainings LLC (Puerto Rico) None None None None None None None
Christian Hassager Rigshospitalet (Denmark) Lundbaek Foundation (A research grant that supports my professorship in critical care.); Novo Nordisk Foundation (A research grant for research on the effect of steroids on post cardiac arrest syndrome.); Abiomed (Local PI in the DanGershock trial) None Abiomed* None None None None
Martin Kluckow University of Sydney (Australia) Australian NHMRC (APP1158494 for transitional research to improve delivery room CPR in an animal model) None None None None None None
Caroline Leech University Hospitals Coventry & Warwickshire NHS Trust (United Kingdom) None None None None None None None
Matthew Levy Johns Hopkins University School of Medicine None None None None None None None
Andrew MacPherson Canadian Red Cross (Canada) None None None None None None None
Taylor McCormick Denver Health Society for Academic Emergency Medicine Foundation* None None None None None None
Mary Ann McNeil University of Minnesota None None None None None None None
Ari Moskowitz Beth Israel Deaconess Medical Center NIH (NIGMS K23 award for sepsis research) None None None None None None
Sabine Nabecker Bern University Hospital, University of Bern (Switzerland) Burgergemeinde Bern (Research Grant for the project: Outcome after Out-of-Hospital Cardiac Arrest (OHCA) in the region of Bern, Switzerland before and after implementation of extracorporeal cardiopulmonary resuscitation (eCPR).Burgergemeinde Bern. Funding program of the Committee of the Natural Historic Museum of Bern. 2019-1077.SFR 3,000)* None None None None European Resuscitation Council (education representative of the “young ERC” group of the European Resuscitation Council)* None
Colm P.F. O’Donnell National Maternity Hospital (Ireland) Chieisi Farmaceutici (Manufacturers provided investigational medicinal product (Curosurf) free of charge for the POPART trial (EudraCT number: 2016-004198-41) of which I am the Chief Investigator) None None None None None None
Peter Paal Hospitallers Brothers Hospital, Paracelsus Medical University (Austria) None None None None None None None
Sarah M. Perman University of Colorado, School of Medicine NIH (K23HL138164) None None None None None None
Tom Quinn Kingston University and St. George’s University of London (United Kingdom) NIHR* None None None None ESC Association Acute Cardiovascular Care (board member)* None
Thomas Rea University of Washington Philips (grant to evaluate community response strategies. We are not evaluating proprietary technology but rather general response strategies. The grant is to my employer, the University of Washington)*; AHA (grant evaluates whether brain oximetry during resuscitation changes during resuscitation and is predictive of outcome. The grant is to my employer, the University of Washington)*; federal government (pending grant to study components of CPR and outcome of cardiac arrest)*; Medtronic Foundation (HeartRescue Consortium. Nonproprietary efforts to improve links in the chain of survival for large population-based regions)*; AHA (investigator in the Strategic Network to Investigate Sudden Cardiac Arrest) None None None None None None
Jon C. Rittenberger Guthrie Medical Center None None None None None None None
Sten Rubertsson Uppsala University and Uppsala University Hospital (Sweden) None None None None None None None
Mario Ruediger TU Dresden, Medical Faculty Carl Gustav Carus Center for feto/neonatal Health (Germany) None None None None None None None
Andrea Scapigliati Catholic University of the Sacred Heart (Italy) None None None None None None None
Stephen M. Schexnayder University of Arkansas/Arkansas Children’s Hospital None None None None None None None
Fred Severyn University of Colorado None None None None None None None
Anne Lee Solevåg Oslo University Hospital (Norway) None None None None None None None
Lynn Thomas St. John Ambulance (United Kingdom) None None None None None None None

This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10 000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10 000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.

*

Modest.

Significant.